HEADER TRANSCRIPTION 05-OCT-18 6HTY TITLE PXR IN COMPLEX WITH P2X4 INHIBITOR COMPOUND 25 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2,NUCLEAR COMPND 3 RECEPTOR COACTIVATOR 1; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: ORPHAN NUCLEAR RECEPTOR PAR1,ORPHAN NUCLEAR RECEPTOR PXR, COMPND 6 PREGNANE X RECEPTOR,STEROID AND XENOBIOTIC RECEPTOR,SXR,NCOA-1,CLASS COMPND 7 E BASIC HELIX-LOOP-HELIX PROTEIN 74,BHLHE74,PROTEIN HIN-2,RIP160, COMPND 8 RENAL CARCINOMA ANTIGEN NY-REN-52,STEROID RECEPTOR COACTIVATOR 1,SRC- COMPND 9 1; COMPND 10 EC: 2.3.1.48; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES; COMPND 13 OTHER_DETAILS: FRAGMENT: PXR, RESIDUES 129-434, K129G IS A CLONING COMPND 14 ARTIFACT; LINKER; SRC-1, RESIDUES 678-700 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2, PXR, NCOA1, BHLHE74, SRC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PXR, SRC-1, CYP3A4 INDUCTION, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR R.C.HILLIG,V.PUETTER,S.WERNER,S.MESCH,A.LAUX-BIEHLMANN,N.BRAEUER, AUTHOR 2 H.DAHLOEF,J.KLINT,A.TER LAAK,E.POOK,I.NEAGOE,R.NUBBEMEYER,S.SCHULZ REVDAT 3 24-JAN-24 6HTY 1 REMARK REVDAT 2 08-JAN-20 6HTY 1 JRNL REVDAT 1 04-DEC-19 6HTY 0 JRNL AUTH S.WERNER,S.MESCH,R.C.HILLIG,A.TER LAAK,J.KLINT,I.NEAGOE, JRNL AUTH 2 A.LAUX-BIEHLMANN,H.DAHLLOF,N.BRAUER,V.PUETTER,R.NUBBEMEYER, JRNL AUTH 3 S.SCHULZ,M.BAIRLEIN,T.M.ZOLLNER,A.STEINMEYER JRNL TITL DISCOVERY AND CHARACTERIZATION OF THE POTENT AND SELECTIVE JRNL TITL 2 P2X4 INHIBITORN-[4-(3-CHLOROPHENOXY) JRNL TITL 3 -3-SULFAMOYLPHENYL]-2-PHENYLACETAMIDE (BAY-1797) AND JRNL TITL 4 STRUCTURE-GUIDED AMELIORATION OF ITS CYP3A4 INDUCTION JRNL TITL 5 PROFILE. JRNL REF J.MED.CHEM. V. 62 11194 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31746599 JRNL DOI 10.1021/ACS.JMEDCHEM.9B01304 REMARK 2 REMARK 2 RESOLUTION. 2.22 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0189 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.15 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 37812 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1991 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.22 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2711 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2930 REMARK 3 BIN FREE R VALUE SET COUNT : 143 REMARK 3 BIN FREE R VALUE : 0.3350 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4869 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 55 REMARK 3 SOLVENT ATOMS : 148 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 69.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.43000 REMARK 3 B22 (A**2) : 1.01000 REMARK 3 B33 (A**2) : 0.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.230 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.189 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.153 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.093 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.942 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5156 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4841 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6961 ; 1.420 ; 1.972 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11239 ; 0.970 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 629 ; 5.400 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 245 ;34.910 ;23.633 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 959 ;16.924 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 37 ;16.542 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 759 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5645 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1070 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2445 ; 4.683 ; 4.366 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2444 ; 4.677 ; 4.366 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3061 ; 7.198 ; 9.775 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3062 ; 7.198 ; 9.778 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2711 ; 5.786 ; 4.859 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2712 ; 5.786 ; 4.860 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3888 ; 8.709 ;10.616 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5715 ;12.042 ;52.587 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5690 ;12.052 ;52.448 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 142 460 B 142 460 19266 0.10 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 138 A 434 REMARK 3 ORIGIN FOR THE GROUP (A): 8.7030 28.6220 29.9090 REMARK 3 T TENSOR REMARK 3 T11: 0.0576 T22: 0.0853 REMARK 3 T33: 0.0951 T12: 0.0182 REMARK 3 T13: -0.0091 T23: -0.0064 REMARK 3 L TENSOR REMARK 3 L11: 3.1002 L22: 1.9740 REMARK 3 L33: 3.7461 L12: -0.4322 REMARK 3 L13: -0.7728 L23: 0.4889 REMARK 3 S TENSOR REMARK 3 S11: 0.0270 S12: 0.3695 S13: 0.0912 REMARK 3 S21: -0.1612 S22: -0.1438 S23: 0.1260 REMARK 3 S31: -0.4198 S32: -0.1726 S33: 0.1167 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 138 B 434 REMARK 3 ORIGIN FOR THE GROUP (A): 54.9250 41.8210 7.9480 REMARK 3 T TENSOR REMARK 3 T11: 0.0310 T22: 0.0843 REMARK 3 T33: 0.0380 T12: -0.0070 REMARK 3 T13: -0.0053 T23: 0.0075 REMARK 3 L TENSOR REMARK 3 L11: 4.1125 L22: 3.0285 REMARK 3 L33: 2.0458 L12: 0.7602 REMARK 3 L13: -0.1767 L23: -0.2665 REMARK 3 S TENSOR REMARK 3 S11: 0.0423 S12: -0.2182 S13: -0.3045 REMARK 3 S21: 0.1668 S22: -0.0120 S23: -0.1035 REMARK 3 S31: 0.1851 S32: 0.0052 S33: -0.0303 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 442 A 461 REMARK 3 ORIGIN FOR THE GROUP (A): 2.4100 12.2690 18.4330 REMARK 3 T TENSOR REMARK 3 T11: 0.1778 T22: 0.2794 REMARK 3 T33: 0.2671 T12: -0.0103 REMARK 3 T13: 0.0218 T23: -0.1777 REMARK 3 L TENSOR REMARK 3 L11: 10.6980 L22: 5.4917 REMARK 3 L33: 6.4874 L12: 0.1265 REMARK 3 L13: -3.4701 L23: 0.6017 REMARK 3 S TENSOR REMARK 3 S11: 0.0431 S12: 0.5465 S13: -0.4024 REMARK 3 S21: 0.0267 S22: -0.0544 S23: 0.0770 REMARK 3 S31: 0.5881 S32: -0.4213 S33: 0.0114 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 442 B 461 REMARK 3 ORIGIN FOR THE GROUP (A): 56.2930 27.0390 -7.3600 REMARK 3 T TENSOR REMARK 3 T11: 0.2701 T22: 0.1567 REMARK 3 T33: 0.2468 T12: -0.0212 REMARK 3 T13: 0.0786 T23: -0.1466 REMARK 3 L TENSOR REMARK 3 L11: 9.4999 L22: 5.6842 REMARK 3 L33: 12.9077 L12: 1.2631 REMARK 3 L13: 1.4088 L23: -1.2713 REMARK 3 S TENSOR REMARK 3 S11: -0.0861 S12: -0.2070 S13: -0.6453 REMARK 3 S21: -0.1564 S22: 0.2443 S23: -0.6088 REMARK 3 S31: 0.6982 S32: 0.4529 S33: -0.1582 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6HTY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1200012083. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.040432 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39804 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.220 REMARK 200 RESOLUTION RANGE LOW (A) : 45.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.22 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC 5.8.0049 REMARK 200 STARTING MODEL: 3HVL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 MICROLITER PROTEIN AT 12.1 MG/ML (IN REMARK 280 20 MILLIMOLAR TRIS PH 7.8, 250 MILLIMOLAR NACL, 2.5 MILLIMOLAR REMARK 280 EDTA, 5% (V/V) GLYCEROL, 5 MM DTT), PREINCUBATED WITH 10 REMARK 280 MILLIMOLAR COMPOUND 15 (FROM 200 MILLIMOLAR STOCK IN DMSO), REMARK 280 MIXED WITH 1 MICROLITER OF RESERVOIR (100 MM IMIDAZOLE PH 8.0, REMARK 280 17 % (V/V) MPD). CRYSTALS ADDITIONALLY SOAKED IN 20 MILLIMOLAR REMARK 280 COMPOUND 15 PRIOR TO DATA COLLECTION. CRYO BUFFER 34% (V/V) MPD REMARK 280 SUPPLEMENTED WITH 20 MILLIMOLAR COMPOUND 15, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.70850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.46450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.30800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.46450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.70850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.30800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 119 REMARK 465 LYS A 120 REMARK 465 LYS A 121 REMARK 465 GLY A 122 REMARK 465 HIS A 123 REMARK 465 HIS A 124 REMARK 465 HIS A 125 REMARK 465 HIS A 126 REMARK 465 HIS A 127 REMARK 465 HIS A 128 REMARK 465 GLY A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 VAL A 140 REMARK 465 GLN A 141 REMARK 465 LEU A 178 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 GLY A 435 REMARK 465 GLY A 436 REMARK 465 SER A 437 REMARK 465 GLY A 438 REMARK 465 GLY A 439 REMARK 465 SER A 440 REMARK 465 SER A 441 REMARK 465 HIS A 442 REMARK 465 SER A 462 REMARK 465 MET B 119 REMARK 465 LYS B 120 REMARK 465 LYS B 121 REMARK 465 GLY B 122 REMARK 465 HIS B 123 REMARK 465 HIS B 124 REMARK 465 HIS B 125 REMARK 465 HIS B 126 REMARK 465 HIS B 127 REMARK 465 HIS B 128 REMARK 465 GLY B 129 REMARK 465 SER B 130 REMARK 465 GLU B 131 REMARK 465 ARG B 132 REMARK 465 THR B 133 REMARK 465 GLY B 134 REMARK 465 THR B 135 REMARK 465 GLN B 136 REMARK 465 PRO B 137 REMARK 465 LEU B 178 REMARK 465 SER B 179 REMARK 465 SER B 180 REMARK 465 GLY B 181 REMARK 465 CYS B 182 REMARK 465 GLU B 183 REMARK 465 LEU B 184 REMARK 465 PRO B 185 REMARK 465 GLU B 186 REMARK 465 SER B 187 REMARK 465 LEU B 188 REMARK 465 GLN B 189 REMARK 465 ALA B 190 REMARK 465 GLY B 433 REMARK 465 SER B 434 REMARK 465 GLY B 435 REMARK 465 GLY B 436 REMARK 465 SER B 437 REMARK 465 GLY B 438 REMARK 465 GLY B 439 REMARK 465 SER B 440 REMARK 465 SER B 441 REMARK 465 SER B 462 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 396 CG - SD - CE ANGL. DEV. = 11.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 193 -56.32 -146.95 REMARK 500 CYS A 207 5.63 -69.95 REMARK 500 CYS A 301 64.33 -112.11 REMARK 500 PHE A 420 -15.66 -145.61 REMARK 500 SER B 192 108.85 -164.92 REMARK 500 CYS B 207 5.02 -69.68 REMARK 500 LEU B 209 59.43 -105.52 REMARK 500 ASP B 230 93.48 -67.28 REMARK 500 CYS B 301 55.62 -112.23 REMARK 500 PHE B 420 -15.18 -146.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GRH B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS B 503 DBREF 6HTY A 129 434 UNP O75469 NR1I2_HUMAN 129 434 DBREF 6HTY A 440 462 UNP Q15788 NCOA1_HUMAN 678 700 DBREF 6HTY B 129 434 UNP O75469 NR1I2_HUMAN 129 434 DBREF 6HTY B 440 462 UNP Q15788 NCOA1_HUMAN 678 700 SEQADV 6HTY MET A 119 UNP O75469 INITIATING METHIONINE SEQADV 6HTY LYS A 120 UNP O75469 EXPRESSION TAG SEQADV 6HTY LYS A 121 UNP O75469 EXPRESSION TAG SEQADV 6HTY GLY A 122 UNP O75469 EXPRESSION TAG SEQADV 6HTY HIS A 123 UNP O75469 EXPRESSION TAG SEQADV 6HTY HIS A 124 UNP O75469 EXPRESSION TAG SEQADV 6HTY HIS A 125 UNP O75469 EXPRESSION TAG SEQADV 6HTY HIS A 126 UNP O75469 EXPRESSION TAG SEQADV 6HTY HIS A 127 UNP O75469 EXPRESSION TAG SEQADV 6HTY HIS A 128 UNP O75469 EXPRESSION TAG SEQADV 6HTY GLY A 129 UNP O75469 LYS 129 CLONING ARTIFACT SEQADV 6HTY GLY A 435 UNP O75469 LINKER SEQADV 6HTY GLY A 436 UNP O75469 LINKER SEQADV 6HTY SER A 437 UNP O75469 LINKER SEQADV 6HTY GLY A 438 UNP O75469 LINKER SEQADV 6HTY GLY A 439 UNP O75469 LINKER SEQADV 6HTY MET B 119 UNP O75469 INITIATING METHIONINE SEQADV 6HTY LYS B 120 UNP O75469 EXPRESSION TAG SEQADV 6HTY LYS B 121 UNP O75469 EXPRESSION TAG SEQADV 6HTY GLY B 122 UNP O75469 EXPRESSION TAG SEQADV 6HTY HIS B 123 UNP O75469 EXPRESSION TAG SEQADV 6HTY HIS B 124 UNP O75469 EXPRESSION TAG SEQADV 6HTY HIS B 125 UNP O75469 EXPRESSION TAG SEQADV 6HTY HIS B 126 UNP O75469 EXPRESSION TAG SEQADV 6HTY HIS B 127 UNP O75469 EXPRESSION TAG SEQADV 6HTY HIS B 128 UNP O75469 EXPRESSION TAG SEQADV 6HTY GLY B 129 UNP O75469 LYS 129 CLONING ARTIFACT SEQADV 6HTY GLY B 435 UNP O75469 LINKER SEQADV 6HTY GLY B 436 UNP O75469 LINKER SEQADV 6HTY SER B 437 UNP O75469 LINKER SEQADV 6HTY GLY B 438 UNP O75469 LINKER SEQADV 6HTY GLY B 439 UNP O75469 LINKER SEQRES 1 A 344 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 A 344 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 A 344 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 A 344 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 A 344 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 A 344 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 A 344 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 A 344 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 A 344 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 A 344 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 A 344 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 A 344 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 A 344 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 A 344 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 A 344 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 A 344 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 A 344 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 A 344 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 A 344 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 A 344 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 A 344 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 A 344 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 A 344 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 A 344 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 A 344 ILE THR GLY SER GLY GLY SER GLY GLY SER SER HIS SER SEQRES 26 A 344 SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU SEQRES 27 A 344 GLN GLU GLY SER PRO SER SEQRES 1 B 344 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 B 344 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 B 344 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 B 344 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 B 344 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 B 344 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 B 344 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 B 344 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 B 344 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 B 344 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 B 344 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 B 344 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 B 344 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 B 344 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 B 344 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 B 344 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 B 344 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 B 344 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 B 344 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 B 344 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 B 344 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 B 344 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 B 344 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 B 344 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 B 344 ILE THR GLY SER GLY GLY SER GLY GLY SER SER HIS SER SEQRES 26 B 344 SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU SEQRES 27 B 344 GLN GLU GLY SER PRO SER HET GOL A 501 6 HET DMS A 502 4 HET DMS A 503 4 HET DMS A 504 4 HET GRH B 501 29 HET DMS B 502 4 HET DMS B 503 4 HETNAM GOL GLYCEROL HETNAM DMS DIMETHYL SULFOXIDE HETNAM GRH (2~{R})-~{N}-[4-(3-CHLORANYLPHENOXY)-3-SULFAMOYL- HETNAM 2 GRH PHENYL]-2-PHENYL-PROPANAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL C3 H8 O3 FORMUL 4 DMS 5(C2 H6 O S) FORMUL 7 GRH C21 H19 CL N2 O4 S FORMUL 10 HOH *148(H2 O) HELIX 1 AA1 THR A 144 PHE A 162 1 19 HELIX 2 AA2 ARG A 193 CYS A 207 1 15 HELIX 3 AA3 GLY A 233 SER A 238 5 6 HELIX 4 AA4 LEU A 239 ILE A 261 1 23 HELIX 5 AA5 ILE A 261 ASP A 266 1 6 HELIX 6 AA6 PRO A 268 VAL A 291 1 24 HELIX 7 AA7 GLY A 314 LEU A 319 1 6 HELIX 8 AA8 GLU A 321 LEU A 333 1 13 HELIX 9 AA9 HIS A 336 PHE A 349 1 14 HELIX 10 AB1 GLN A 358 ARG A 381 1 24 HELIX 11 AB2 GLN A 383 ARG A 387 5 5 HELIX 12 AB3 PHE A 388 HIS A 418 1 31 HELIX 13 AB4 THR A 422 GLY A 430 1 9 HELIX 14 AB5 THR A 446 ARG A 448 5 3 HELIX 15 AB6 HIS A 449 GLU A 458 1 10 HELIX 16 AB7 LEU B 138 LEU B 143 5 6 HELIX 17 AB8 THR B 144 PHE B 162 1 19 HELIX 18 AB9 GLU B 194 CYS B 207 1 14 HELIX 19 AC1 GLY B 233 SER B 238 5 6 HELIX 20 AC2 LEU B 239 ILE B 261 1 23 HELIX 21 AC3 ILE B 261 ASP B 266 1 6 HELIX 22 AC4 PRO B 268 VAL B 291 1 24 HELIX 23 AC5 GLY B 314 LEU B 319 1 6 HELIX 24 AC6 GLU B 321 LEU B 333 1 13 HELIX 25 AC7 HIS B 336 PHE B 349 1 14 HELIX 26 AC8 GLN B 358 ARG B 381 1 24 HELIX 27 AC9 GLN B 383 ARG B 387 5 5 HELIX 28 AD1 PHE B 388 HIS B 418 1 31 HELIX 29 AD2 THR B 422 GLY B 430 1 9 HELIX 30 AD3 SER B 444 HIS B 449 1 6 HELIX 31 AD4 HIS B 449 GLU B 458 1 10 SHEET 1 AA110 PHE A 292 ASN A 293 0 SHEET 2 AA110 THR A 298 CYS A 301 -1 O THR A 298 N ASN A 293 SHEET 3 AA110 LEU A 304 LEU A 308 -1 O LEU A 304 N CYS A 301 SHEET 4 AA110 VAL A 211 ARG A 216 -1 N GLN A 214 O SER A 305 SHEET 5 AA110 VAL A 222 LYS A 226 -1 O TYR A 225 N LEU A 213 SHEET 6 AA110 VAL B 222 LYS B 226 -1 O VAL B 222 N LYS A 226 SHEET 7 AA110 VAL B 211 ARG B 216 -1 N LEU B 213 O TYR B 225 SHEET 8 AA110 LEU B 304 LEU B 308 -1 O SER B 305 N GLN B 214 SHEET 9 AA110 THR B 298 CYS B 301 -1 N CYS B 301 O LEU B 304 SHEET 10 AA110 PHE B 292 ASN B 293 -1 N ASN B 293 O THR B 298 SITE 1 AC1 1 MET A 329 SITE 1 AC2 4 GLU A 337 HOH A 612 HOH A 613 ARG B 387 SITE 1 AC3 2 LYS A 160 HIS A 168 SITE 1 AC4 2 MET A 394 HOH A 629 SITE 1 AC5 12 LEU B 209 SER B 247 PHE B 251 PHE B 281 SITE 2 AC5 12 CYS B 284 GLN B 285 PHE B 288 TRP B 299 SITE 3 AC5 12 MET B 323 HIS B 407 ILE B 414 PHE B 420 SITE 1 AC6 3 GLU B 337 TYR B 340 HOH B 614 SITE 1 AC7 3 VAL A 177 VAL B 177 TRP B 223 CRYST1 85.417 88.616 104.929 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011707 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011285 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009530 0.00000